Tenofovir--a new option for combination therapy
Polk, B.
Medizinische Monatsschrift für Pharmazeuten 25(4): 140-141
2002
ISSN/ISBN: 0342-9601 PMID: 12017125 Document Number: 546554
Document emailed within 1 workday
Related Documents
Baeten, J.M.; Donnell, D.; Mugo, N.R.; Ndase, P.; Thomas, K.K.; Campbell, J.D.; Wangisi, J.; Tappero, J.W.; Bukusi, E.A.; Cohen, C.R.; Katabira, E.; Ronald, A.; Tumwesigye, E.; Were, E.; Fife, K.H.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Kidoguchi, L.; Coombs, R.W.; Hendrix, C.; Marzinke, M.A.; Frenkel, L.; Haberer, J.E.; Bangsberg, D.; Celum, C. 2014: Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial Lancet. Infectious Diseases 14(11): 1055-1064Denneman, L.; Cohen, S.; Godfried, M.H.; van Leeuwen, E.; Nellen, J.F.; Kuijpers, T.W.; Pajkrt, D.; van de Plas, A.; Smit, C.; Weijsenfeld, A.M.; Scherpbier, H.J.; Bunders, M.J. 2017: In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply Aids 31(4): 596-598
Herlihy, J.M.; Hamomba, L.; Bonawitz, R.; Goggin, C.E.; Sambambi, K.; Mwale, J.; Musonda, V.; Musokatwane, K.; Hopkins, K.L.; Semrau, K.; Hammond, E.E.; Duncan, J.; Knapp, A.B.; Thea, D.M. 2015: Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: a Prototype for Option B+? Journal of Acquired Immune Deficiency Syndromes 70(4): E123-E129
Margot, N.A.; Miller, M.D. 2005: In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1 Antiviral Therapy 10(2): 343-348
Podzamczer, D.; Ferrer, E.; Gatell, J.M.; Niubo, J.; Dalmau, D.; Leon, A.; Knobel, H.; Polo, C.; Iniguez, D.; Ruiz, I. 2005: Early virological failure with a combination of tenofovir, didanosine and efavirenz Antiviral Therapy 10(1): 171-177
Snopková, S.; Havlíčková, K.ři.; Husa, P. 2016: Tenofovir alafenamide fumarate - a new generation of tenofovir Klinicka Mikrobiologie a Infekcni Lekarstvi 22(3): 111-117
Pujari, S.; Dravid, A.; Gupte, N.; Joshi, K.; Bele, V. 2008: Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India Medscape Journal of Medicine 10(8): 196
Sauvage, A-Sophie.; Darcis, G.; Moutschen, M. 2016: Update in HIV therapy: tenofovir alafenamide Revue medicale suisse 12(527): 1367-1369
Hioki, M.; Kagawa, S.; Fujiwara, T.; Sakai, R.; Kojima, T.; Watanabe, Y.; Hashimoto, Y.; Uno, F.; Tanaka, N.; Fujiwara, T. 2008: Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy International Journal of Cancer 122(11): 2628-2633
Bender, M.A.; Kumarasamy, N.; Mayer, K.H.; Wang, B.; Walensky, R.P.; Flanigan, T.; Schackman, B.R.; Scott, C.A.; Lu, Z.; Freedberg, K.A. 2010: Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 50(3): 416-425
Mauss, S.; Milinkovic, A.; Hoffmann, C.; Holm, S.; Berger, F.; Martínez, E.; Kuhlmann, B.; Gatell, J.é; Schmutz, G. 2005: Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine Aids 19(1): 101-102
Akamatsu, H.; Tsukuura, T.; Matsunaga, H.; Suzuki, A. 1993: Study of combination therapy for thymoma: a case of stage IV which presented as total spinal block caused by epidural metastasis and which preoperative combination therapy was effective for minimizing the tumor Kyobu Geka. Japanese Journal of Thoracic Surgery 46(13): 1156-1160
Ozdemir, O.; Saylan, M.; Pakel, H.; Lescrauwaet, B. 2011: PIN8 a Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without "Tenofovir Add-on as Needed" and Lamivudine with or without "Tenofovir Add-on as Needed" in the Treatment of Chronic Hepatitis B Infection in Turkey Value in Health 14(7): A266-A267
Beatty, G.; Hunt, P.; Smith, A.; Hoh, R.; Huang, W.; Martin, J.; Deeks, S.G. 2006: A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide Antiviral Therapy 11(3): 315-319
Sadek, S.; Medina, Jé.; Arias, M.; Sennesael, J.; Squifflet, J-Paul.; Vogt, B. 2002: Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study Transplantation 74(4): 511-517
Piketty, C.; Gérard, L.; Chazallon, C.; Marcelin, A.-G.èv.; Clavel, F.ço.; Taburet, A.-M.; Calvez, V.; Madelaine-Chambrin, I.; Molina, J.-M.; Aboulker, J.-P.; Girard, P.-M. 2006: Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial Antiviral Therapy 11(2): 213-221
Ramlagan, S.; Peltzer, K.; Ruiter, R.A.C.; Barylski, N.A.; Weiss, S.M.; Sifunda, S. 2018: Prevalence and Factors Associated with Fixed-Dose Combination Antiretroviral Drugs Adherence among HIV-Positive Pregnant Women on Option B Treatment in Mpumalanga Province, South Africa International Journal of Environmental Research and Public Health 15(1)
DoBias, M. 2009: Still an option. Senate leaders mull public option, may lose support Modern Healthcare 39(43): 8-9
Mukai, M.; Ando, K.; Koike, S.; Ishikawa, T.; Ryu, M.; Nagashima, T.; Nagao, K.; Isono, K. 1986: Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 1): 556-562
Ortleb, J. 2003: New option for successful therapy of chronic hepatitis B Deutsche Medizinische Wochenschrift 128(28-29): 1565